Scientists in Brazil are developing a vaccine against cocaine addiction, called Calixcoca. The vaccine has shown promising results in animal tests and is now ready to enter human trials.
The Calixcoca works by stimulating the body to produce antibodies that bind to cocaine molecules in the bloodstream. These antibodies make the cocaine molecules too large to pass into the brain, where they would normally produce their euphoric effects.
The vaccine has also demonstrated a reduction in the risk of overdose and may protect breastfeeding infants from the effects of cocaine.
If successful, Calixcoca could be a new revolutionary treatment for cocaine addiction. It would be the first vaccine used to treat any type of addiction and could help millions of people around the world break free from cocaine dependence.
The development of Calixcoca is particularly significant in Brazil, which is the second-largest consumer of cocaine in the world. The vaccine could have a major impact on public health in Brazil and also help reduce crime and social problems associated with its addiction.
Human trials for Calixcoca are expected to begin in early 2024. If the trials are successful, the vaccine could be available to the public in a few years.
Source: Vox